Suriname - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Suriname Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases grew 5.9% year on year. In 2019, the country was number 244 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 12 Cases. India ranked the highest with 66,255 Cases in 2019, that is +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 12.00 |
| 2018 | 13.00 |
| 2017 | 8.00 |
| 2016 | 4.00 |
| 2015 | 8.00 |
Download all data from 2005 to 2019
How does Suriname rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 244 |
#244
Netherlands
|
12 | 2019 | +0.0 % | +11.4 % | View data | |
| 244 |
#244
Suriname
|
12 | 2019 | -7.7 % | +5.9 % | View data | |
| 248 |
#248
Ireland
|
11 | 2019 | +22.2 % | +40.6 % | View data | |